Cognitive reserve in multiple sclerosis: Protective effects of education

Multiple Sclerosis

Volumn 21, Issue 10, 2015, Pages 1312-1321

  Da Silva, Ana Martins ^a,b   Cavaco, Sara ^a,b   Moreira, Inês ^b   Bettencourt, Andreia ^b   Santos, Ernestina ^a,b   Pinto, Cláudia ^a,b   Gonçalves, Alexandra ^a,b   Coutinho, Ester ^a   Samões, Raquel ^a   Dias, Cláudia C ^b   Teixeira Pinto, Armando ^b,d   Da Silva, Berta Martins ^b   Montalban, Xavier ^c  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Centre d Esclerosi Múltiple de Catalunya Cemcat   (Spain)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Apolipoprotein E; cognitive deficit; cognitive reserve; education; genotype; human leukocyte antigen; multiple sclerosis; protective factors

Indexed keywords

APOLIPOPROTEIN E; HLA DRB1 ANTIGEN; IMMUNOMODULATING AGENT;

ADOLESCENT; ADULT; AGE; AGED; APOE GENE; ARTICLE; BRAIN PROTECTION; CLINICAL FEATURE; COGNITIVE DEFECT; COGNITIVE RESERVE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; EDUCATIONAL STATUS; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEREDITY; HLA DRB1 GENE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS SEVERITY SCALE; NEUROPSYCHOLOGICAL TEST; RATING SCALE; SCORING SYSTEM; SEX; COGNITION; DISABILITY; EDUCATION; GENETIC PREDISPOSITION; GENETICS; MEMORY; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COGNITION; COGNITIVE RESERVE; DISABILITY EVALUATION; EDUCATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMORY; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84940907511     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515581874     Document Type: Article

References (34)

1. Stern Y,. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002; 8: 448-460.
2. Stern Y,. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol 2012; 11: 1006-1012.
3. Benedict RH, Zivadinov R,. Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 2011; 7: 332-342.
4. Staff RT, Murray AD, Deary IJ,. What provides cerebral reserve? Brain 2004; 127: 1191-1199.
5. Meng X, D'Arcy C,. Education and dementia in the context of the cognitive reserve hypothesis: A systematic review with meta-analyses and qualitative analyses. PloS One 2012; 7: e38268.
6. Benedict RH, Morrow SA, Weinstock Guttman B,. Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients. J Int Neuropsychol Soc 2010; 16: 829-835.
7. Bonnet MC, Deloire MS, Salort E,. Evidence of cognitive compensation associated with educational level in early relapsing-remitting multiple sclerosis. J Neurolog Sci 2006; 251: 23-28.
8. Pinter D, Sumowski J, DeLuca J,. Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis. PLoS One 2014; 9: e87567.
9. Sumowski JF, Rocca MA, Leavitt VM,. Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it. Neurology 2013; 80: 2186-2193.
10. Amato MP, Goretti B, Ghezzi A,. Cognitive and psychosocial features in childhood and juvenile MS: Two-year follow-up. Neurology 2010; 75: 1134-1140.
11. Amato MP, Ponziani G, Siracusa G,. Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Arch Neurol 2001; 58: 1602-1606.
12. Ghaffar O, Fiati M, Feinstein A,. Occupational attainment as a marker of cognitive reserve in multiple sclerosis. PLoS One 2012; 7: e47206.
13. Morgado J, Maruta C, Guerreiro M,. Novos Valores Normativos do Mini-Mental State Examination. [ New normative values of the Mini-Mental State Examination ]. Sinapse 2009; 9: 10-16.
14. Meneses RF, Pais-Ribeiro JL, Da Silva AM,. Neuropsychological predictors of quality of life in focal epilepsy. Seizure 2009; 18: 313-319.
15. Sumowski JF, Chiaravalloti N, DeLuca J,. Cognitive reserve protects against cognitive dysfunction in multiple sclerosis. J Clin Exp Neuropsychol 2009; 31: 913-926.
16. Amato MP, Razzolini L, Goretti B,. Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study. Neurology 2013; 80: 1728-1733.
17. Sumowski JF, Chiaravalloti N, Wylie G,. Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis. J Int Neuropsychol Soc 2009; 15: 606-612.
18. Sumowski JF, Wylie GR, Gonnella A,. Premorbid cognitive leisure independently contributes to cognitive reserve in multiple sclerosis. Neurology 2010; 75: 1428-1431.
19. Fernandes JMI, Gonçalves A, Pinto C,. Fluência verbal na doença de Huntington. [ Verbal fluency in Huntington's disease ]. Sinapse 2013; 13: 212.
20. Greenaway MC, Smith GE, Tangalos EG,. Mayo older Americans normative studies: Factor analysis of an expanded neuropsychological battery. Clin Neuropsychologist 2009; 23: 7-20.
21. Feinstein A, Lapshin H, O'Connor P,. Sub-threshold cognitive impairment in multiple sclerosis: The association with cognitive reserve. J Neurol 2013; 260: 2256-2261.
22. Sumowski JF, Rocca MA, Leavitt VM,. Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS. Neurology 2014; 82: 1776-1783.
23. Patti F, Amato MP, Trojano M,. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: Baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 2009; 15: 779-788.
24. Lynch SG, Parmenter BA, Denney DR,. The association between cognitive impairment and physical disability in multiple sclerosis. Mult Scler 2005; 11: 469-476.
25. Siepman TA, Janssens AC, De Koning I,. The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis. J Neurol 2008; 255: 910-916.
26. Huijbregts SC, Kalkers NF, De Sonneville LM,. Differences in cognitive impairment of relapsing-remitting, secondary and primary progressive MS. Neurology 2004; 63: 335-339.
27. Ruet A, Deloire M, Charre-Morin J,. Cognitive impairment differs between primary progressive and relapsing-remitting MS. Neurology 2013; 80: 1501-1508.
28. Calabrese M, Agosta F, Rinaldi F,. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009; 66: 1144-1150.
29. Ghaffar O, Feinstein A,. APOE epsilon4 and cognitive dysfunction in multiple sclerosis: A review. J Neuropsychiatry Clin Neurosci 2010; 22: 155-165.
30. Van der Walt A, Stankovich J, Bahlo M,. Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition. Mult Scler 2011; 17: 344-352.
31. Zivadinov R, Weinstock-Guttman B, Benedict R,. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Hum Mol Genet 2007; 16: 2659-2668.
32. Peyser JM, Rao SM, LaRocca NG,. Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol 1990; 47: 94-97.
33. Rao SM, Leo GJ, Bernardin L,. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns and prediction. Neurology 1991; 41: 685-691.
34. Amato MP, Zipoli V, Portaccio E,. Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies. J Neurolog Sci 2006; 245: 41-46.